Trial
NCT00701077
DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Brugada Syndrome
Intervention
3,4-Di-amino-Pyridine
Why stopped
recruitments issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-07